BACKGROUND: Glioma patients are not only confronted with the diagnosis and treatment of a brain tumor, but also with changes in cognitive and neurological functioning that can profoundly affect their daily lives. At present, little is known about the relationship between cognitive functioning and health-related quality of life (HRQOL) during the disease trajectory. We studied this association in low-grade glioma (LGG) patients with stable disease at an average of 6 years after diagnosis. METHODS: Patients and healthy controls underwent neuropsychological testing and completed self-report measures of generic (MOS SF36) and disease-specific (EORTC BN20) HRQOL. Associations were determined with Pearson correlations, and corrections for multipl...
Abstract Neurocognitive function and quality of life are important clinical outcome measures for pat...
Standard therapeutic options for brain tumors include surgery, radiotherapy, and chemotherapy. Unfor...
We aimed to expand our knowledge about the level of neurocognitive functioning (NCF) and health-rel...
BACKGROUND: Glioma patients are not only confronted with the diagnosis and treatment of a brain tumo...
Background: The preferred management of patients with suspected low-grade gliomas (S-LGG) remains co...
To evaluate the health-related quality of life (HRQOL) and cognitive functioning of high-grade gliom...
Aim: Understanding and supporting quality of life (QoL) and daily functioning in glioma patients is ...
Purpose: Clinical trials in glioma patients with neurocognitive deficits face challenges due to lack...
Outcomes for patients with lower-grade gliomas (LrGGs) continue to improve with advances in molecula...
Purpose: Low-grade glioma (LGG) patients may face health-related quality-of-life (HRQoL) impairments...
Survival outcomes for patients with lower grade gliomas (LrGG) continue to improve. However, damage ...
Background: Studies in cancer and noncancer populations demonstrate lower than expected correlations...
Objective: To systematically review the literature for studies on cognitive functioning in patients ...
Background: Diffuse gliomas (WHO grade II–IV) are progressive primary brain tumors with great variab...
Purpose Clinical trials in glioma patients with neurocognitive deficits face challenges due to lacki...
Abstract Neurocognitive function and quality of life are important clinical outcome measures for pat...
Standard therapeutic options for brain tumors include surgery, radiotherapy, and chemotherapy. Unfor...
We aimed to expand our knowledge about the level of neurocognitive functioning (NCF) and health-rel...
BACKGROUND: Glioma patients are not only confronted with the diagnosis and treatment of a brain tumo...
Background: The preferred management of patients with suspected low-grade gliomas (S-LGG) remains co...
To evaluate the health-related quality of life (HRQOL) and cognitive functioning of high-grade gliom...
Aim: Understanding and supporting quality of life (QoL) and daily functioning in glioma patients is ...
Purpose: Clinical trials in glioma patients with neurocognitive deficits face challenges due to lack...
Outcomes for patients with lower-grade gliomas (LrGGs) continue to improve with advances in molecula...
Purpose: Low-grade glioma (LGG) patients may face health-related quality-of-life (HRQoL) impairments...
Survival outcomes for patients with lower grade gliomas (LrGG) continue to improve. However, damage ...
Background: Studies in cancer and noncancer populations demonstrate lower than expected correlations...
Objective: To systematically review the literature for studies on cognitive functioning in patients ...
Background: Diffuse gliomas (WHO grade II–IV) are progressive primary brain tumors with great variab...
Purpose Clinical trials in glioma patients with neurocognitive deficits face challenges due to lacki...
Abstract Neurocognitive function and quality of life are important clinical outcome measures for pat...
Standard therapeutic options for brain tumors include surgery, radiotherapy, and chemotherapy. Unfor...
We aimed to expand our knowledge about the level of neurocognitive functioning (NCF) and health-rel...